Amgen (AMGN) Copletes Mustafa Nevzat Pharma Acquisition
Amgen (Nasdaq: AMGN) announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company. The all-cash transaction significantly expands Amgen's presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Amgen (AMGN), Celgene (CELG) see upside action
- Full Circle Capital (FULL) to Merge with Great Elm Capital (GEC)
- Fresenius Near Deal to Acquire Pfizer's (PFE) Medical Devices Unit - MarketWatch
Create E-mail Alert Related CategoriesCorporate News, Mergers and Acquisitions
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!